Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (119)
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
1,632
Price
$1.57
Total Value
$2.56K
Shares Held After
59,583
% of Holdings
2.7%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
16,164
Price
$1.57
Total Value
$25.38K
Shares Held After
590,175
% of Holdings
2.7%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
262,682
Price
$15.31
Total Value
$4.02M
Shares Held After
12,494,481
% of Holdings
2.1%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
2,299
Price
$15.35
Total Value
$35.29K
Shares Held After
12,231,799
% of Holdings
0.0%
Connect Biopharma Holdings Ltd (CNTB)
Huang James — Director
Shares
150,000
Price
$2.48
Total Value
$371.61K
Shares Held After
13,310,000
% of Holdings
1.1%
Ascendis Pharma A/S (ASND)
SMITH SCOTT THOMAS — EVP & Chief Financial Officer
Shares
250
Price
$223.32
Total Value
$55.83K
Shares Held After
4,267
% of Holdings
5.9%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
100
Price
$223.50
Total Value
$22.35K
Shares Held After
900
% of Holdings
11.1%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$222.30
Total Value
$44.46K
Shares Held After
800
% of Holdings
25.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$223.76
Total Value
$44.75K
Shares Held After
600
% of Holdings
33.3%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
2,129
Price
$2.57
Total Value
$5.47K
Shares Held After
9,970
% of Holdings
21.4%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,786
Price
$2.57
Total Value
$4.59K
Shares Held After
17,131
% of Holdings
10.4%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,829
Price
$2.57
Total Value
$4.70K
Shares Held After
9,840
% of Holdings
18.6%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,582
Price
$2.57
Total Value
$4.07K
Shares Held After
9,176
% of Holdings
17.2%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
2,292
Price
$2.57
Total Value
$5.89K
Shares Held After
10,758
% of Holdings
21.3%
MediWound Ltd. (MDWD)
Rubinstein Samuel — Director
Shares
150
Price
$14.33
Total Value
$2.15K
Shares Held After
2,993
% of Holdings
5.0%
Q32 Bio Inc. (QTTB)
ORBIMED ADVISORS LLC — Director
Shares
625,000
Price
$8.00
Total Value
$5.00M
Shares Held After
625,000
% of Holdings
100.0%
Q32 Bio Inc. (QTTB)
ORBIMED ADVISORS LLC — Director
Shares
1,250,000
Price
$8.00
Total Value
$10.00M
Shares Held After
3,502,987
% of Holdings
35.7%
Q32 Bio Inc. (QTTB)
Xu Diyong — Director
Shares
625,000
Price
$8.00
Total Value
$5.00M
Shares Held After
625,000
% of Holdings
100.0%
Q32 Bio Inc. (QTTB)
Xu Diyong — Director
Shares
1,250,000
Price
$8.00
Total Value
$10.00M
Shares Held After
3,502,987
% of Holdings
35.7%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Ghiath M. — Director
Shares
8,539,709
Price
$0.59
Total Value
$5.00M
Shares Held After
22,092,068
% of Holdings
38.7%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
250
Price
$2.30
Total Value
$575.00
Shares Held After
5,779
% of Holdings
4.3%
Annexon, Inc. (ANNX)
Satter Muneer A — Director
Shares
613,497
Price
$5.41
Total Value
$3.32M
Shares Held After
10,342,134
% of Holdings
5.9%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
2,000
Price
$2.00
Total Value
$4.00K
Shares Held After
5,529
% of Holdings
36.2%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
4,500
Price
$1.07
Total Value
$4.82K
Shares Held After
62,514
% of Holdings
7.2%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Jerrold B — Director
Shares
6,400
Price
$7.91
Total Value
$50.62K
Shares Held After
520,284
% of Holdings
1.2%
aTYR PHARMA INC (ATYR)
SCHIMMEL PAUL — Director
Shares
100,000
Price
$0.50
Total Value
$49.63K
Shares Held After
779,143
% of Holdings
12.8%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Faisal Ghiath — Director
Shares
122,174
Price
$0.41
Total Value
$50.01K
Shares Held After
125,574
% of Holdings
97.3%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
23,190
Price
$1.06
Total Value
$24.47K
Shares Held After
58,014
% of Holdings
40.0%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,000
Price
$18.21
Total Value
$36.42K
Shares Held After
20,000
% of Holdings
10.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$239.37
Total Value
$47.87K
Shares Held After
400
% of Holdings
50.0%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$236.24
Total Value
$47.25K
Shares Held After
200
% of Holdings
100.0%
Outlook Therapeutics, Inc. (OTLK)
Haddadin Yezan Munther — Director
Shares
34,000
Price
$0.44
Total Value
$14.96K
Shares Held After
37,167
% of Holdings
91.5%
Outlook Therapeutics, Inc. (OTLK)
THURMAN RANDY H — Director
Shares
5,000
Price
$0.43
Total Value
$2.15K
Shares Held After
5,593
% of Holdings
89.4%
Outlook Therapeutics, Inc. (OTLK)
HILZINGER KURT J — Director
Shares
400,000
Price
$0.44
Total Value
$176.52K
Shares Held After
423,655
% of Holdings
94.4%
Serina Therapeutics, Inc. (SER)
Venkatesan Jay — Director
Shares
589
Price
$1.78
Total Value
$1.05K
Shares Held After
589
% of Holdings
100.0%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
15,950
Price
$1.05
Total Value
$16.71K
Shares Held After
34,824
% of Holdings
45.8%
HCW Biologics Inc. (HCWB)
Byam Rebecca — Chief Financial Officer
Shares
14,235
Price
$1.41
Total Value
$20.00K
Shares Held After
57,245
% of Holdings
24.9%
HCW Biologics Inc. (HCWB)
GARRETT SCOTT T — Director
Shares
177,936
Price
$1.41
Total Value
$250.00K
Shares Held After
203,441
% of Holdings
87.5%
HCW Biologics Inc. (HCWB)
Wong Hing C — Director
Shares
113,879
Price
$1.41
Total Value
$160.00K
Shares Held After
615,790
% of Holdings
18.5%
Vaxart, Inc. (VXRT)
Watson W. Mark — Director
Shares
10,000
Price
$0.65
Total Value
$6.53K
Shares Held After
134,125
% of Holdings
7.5%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
10,000
Price
$1.93
Total Value
$19.30K
Shares Held After
20,000
% of Holdings
50.0%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$9.81
Total Value
$981.30K
Shares Held After
836,000
% of Holdings
12.0%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
3,118
Price
$1.69
Total Value
$5.27K
Shares Held After
57,951
% of Holdings
5.4%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
30,882
Price
$1.69
Total Value
$52.19K
Shares Held After
574,011
% of Holdings
5.4%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
3,420
Price
$1.04
Total Value
$3.56K
Shares Held After
18,874
% of Holdings
18.1%
Serina Therapeutics, Inc. (SER)
WILSON KAREN J — Director
Shares
10,000
Price
$1.77
Total Value
$17.70K
Shares Held After
10,000
% of Holdings
100.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Firestone Karen — Director
Shares
3,800
Price
$13.51
Total Value
$51.34K
Shares Held After
66,900
% of Holdings
5.7%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
5,154
Price
$1.56
Total Value
$8.04K
Shares Held After
54,833
% of Holdings
9.4%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
51,056
Price
$1.56
Total Value
$79.65K
Shares Held After
543,129
% of Holdings
9.4%
Kalaris Therapeutics, Inc. (KLRS)
AKKARAJU SRINIVAS — Director
Shares
244,300
Price
$4.83
Total Value
$1.18M
Shares Held After
2,224,147
% of Holdings
11.0%
Showing 1–50 of 119 transactions (page 1 of 3)